What MTS Medical does

MTS Medical AG is a privately held German medical device manufacturer founded in 1993 and headquartered in Konstanz, Germany, specializing in non-invasive, regenerative therapies based on its proprietary Spark Wave Technology. The company's electrohydraulic shockwave systems generate therapeutic pulses through detonative spark discharge, applying precise energy within a scientifically validated PureWave therapeutic window to stimulate cellular activity, tissue regeneration, and blood circulation. Its portfolio addresses four clinical verticals: urology (urogold100 for erectile dysfunction, Peyronie's disease, and chronic pelvic pain; lithogold380 for extracorporeal shockwave lithotripsy), orthopaedics and sports medicine (orthogold100 and orthogold280 for musculoskeletal disorders), dermatology and wound care (dermagold100 for diabetic foot ulcers, burns, and post-operative healing), and traumatology. The lithogold380 holds FDA clearance, while broader portfolio devices comply with EU Medical Device Directive 93/42/EEC, and the technology is backed by the ISMST 2023 Guidelines and 100+ scientific publications. The core technology is grounded in a foundational European patent (EP09111804, 1999) covering optimized electrohydraulic shockwave design.

MTS Medical sells devices through a hybrid go-to-market model combining direct enterprise field sales to hospitals, clinics, and healthcare professionals with a global distribution network of 30+ trusted channel partners in 30+ countries. Quote-based hardware pricing is supplemented by service revenue from certified training, technical support, and quality assurance, with flexible pricing tailored for clinics and hospitals of varying sizes. Three specialized applicator platforms (Focused OE050, Soft-Focused OE035, and Broad-Focused OP155) span penetration depths from 60 mm to 118 mm at 5 MPa, enabling indication-specific dosing for urology, orthopaedics, dermatology, and (neuro-)muscular applications. The company extends customer engagement through the MySpark client portal and the ED-Information.com patient referral network, which directs patients to urogold100 treatment centers worldwide.

The company is led by co-founders Ralph Reitmajer (Management Board, originator of the foundational electrohydraulic shockwave patent) and Nikolaus Hopfenzitz (Supervisory Board Chairman, who established the first German mobile shockwave clinic joint venture expanding to 34 outpatient centers), alongside Management Board member Dr. Benjamin Schullcke. Ownership is founder-led with no disclosed private equity, venture capital, or parent company affiliations, indicating a self-funded operating profile. Manufacturing and corporate operations are concentrated at the Konstanz facility (Robert-Bosch-Str. 18, registered as MTS Medical AG, HRB 731093, VAT-ID DE282675972), with global reach delivered via partner-led distribution rather than owned international subsidiaries.

Name

MTS Medical

Legal name

MTS Medical AG

Website

https://mts-medical.com

Company type

Private

Founded year

1993

Operating status

Operating

Headcount range

51–100 employees

Short description

MTS Medical AG is a German medical device manufacturer specializing in electrohydraulic Spark Wave Technology for non-invasive treatment in urology, orthopaedics, dermatology/wound care, and lithotripsy, selling devices and applicators to hospitals, clinics, and healthcare professionals through direct sales and a 30+ country distribution network.

Ownership category

akta.pro rank

Product category

Shockwave Therapy Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices) (HLAHAMAG)

akta.pro secondary industries

Kidney Stone Management & Lithotripsy Devices (HLAHAKAI), Energy-Based Surgical Devices (Electrosurgery, RF, Ultrasonic, Laser) (HLAHADAC)

Keywords

• Shockwave therapy devices
• Medical device manufacturing
• Extracorporeal lithotripsy equipment
• Orthopedic shockwave therapy
• Urology medical devices

Headquarters

HQ city

Konstanz

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations

Revenue model

1. Medical Device Sales: Sale of Spark Wave therapy devices (urologold100, orthogold100, orthogold280, dermagold100, lithogold380) to hospitals, clinics, and healthcare professionals. Devices are sold with accompanying applicators and accessories for specific treatment applications.
2. Service and Support: Comprehensive support services including certified training, quality assurance, and technical support provided to device purchasers for seamless integration of shockwave therapy into their practices.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels9 records

Core offering

MTS Medical manufactures and sells medical devices based on proprietary Spark Wave Technology (electrohydraulic shockwave therapy) for non-invasive regenerative treatments in urology, orthopaedics/traumatology, dermatology/wound care, and lithotripsy. Their product portfolio includes portable and stationary devices (urogold100, orthogold100, orthogold280, dermagold100, lithogold380) used by hospitals, clinics, and healthcare professionals in 30+ countries. The devices use interchangeable applicators (Focused, Soft-Focused, Broad-Focused) to deliver therapeutic shockwaves for cellular regeneration.

Product overview

MTS Medical offers a portfolio of medical device products centered on Spark Wave Technology, an advanced electrohydraulic shockwave therapy system. The product line includes specialized devices for three therapy areas: urology (urogold100 for sexual health, lithogold380 for lithotripsy), orthopaedics (orthogold100 and orthogold280 for musculoskeletal/sports medicine), and dermatology (dermagold100 for wound healing and skin conditions). These devices operate with interchangeable applicators (OE050, OE035, OP155 series) offering focused, soft-focused, or broad-focused shockwave delivery. The company also provides the MySpark client portal for customer support. MTS Medical's technology is backed by clinical evidence, ISMST 2023 guidelines, and scientific publications, with devices manufactured in Germany and distributed internationally.

Differentiator

Problem solved

Functional benefit

Brands

• urogold100: Spark Wave Therapy System for urological disorders including erectile dysfunction and chronic pelvic pain.
• orthogold100
• orthogold280
• lithogold380
• dermagold100
• dermagold
• Spark Wave Technology
• PureWave

Products and services

• urogold100 A portable Spark Wave therapy system for urological and men's health applications including erectile dysfunction, Peyronie's disease, chronic pelvic pain syndrome, and chronic prostatitis. Features advanced electrohydraulic shockwave technology with focused or broad-focused applicators. Dimensions: 21.8 x 40 x 45.9 cm, Weight: 18 kg / 21 kg. Targeted at urology clinics and men's health practices.
• lithogold380 A next-generation extracorporeal shockwave lithotripsy device for tissue-friendly and efficient treatment of renal stones and other urological indications. FDA cleared. Dimensions: 1130 x 1580 x 1500 mm, Weight: 234 kg. Targeted at hospitals and lithotripsy treatment facilities.
• orthogold100

Quantifiable outcome

• 30+ countries with international cooperation
• +3 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature10 records

Partnerships

Three partnerships are on record, tiered core, minor and moderate.

• ISMST (International Society of Medical Shockwave Treatment)coreStrategic or Co-development PartnerISMST is the governing body for medical shockwave therapy. MTS Spark Wave Technology is backed by ISMST 2023 Guidelines, demonstrating therapeutic excellence, reliability and safety according to international medical standards.
• ED-Information.comminorChannel Partner/ Reseller/ DistributorPatient referral portal enabling patients to find nearest urogold100 treatment centers. Supports demand generation for urology treatment network.
• Nature Scientific ReportsmoderateStrategic or Co-development PartnerPeer-reviewed research publication providing scientific validation for Spark Wave Technology's therapeutic window parameters and their influence on cellular activity.

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• EDAP TMS: French-listed company commercialising the Sonolith and Focal One ranges for kidney-stone lithotripsy and prostate tissue ablation. Direct, focused competitor to MTS's lithogold380 in urology capital equipment.
• Storz Medical: Swiss manufacturer of focused and radial shockwave therapy (ESWT) and lithotripsy devices across urology, orthopaedics, aesthetics, and cardiology. Closest direct peer to MTS: same electrohydraulic/spark discharge heritage, same device categories, same global hospital/clinic channel.
• Dornier MedTech: German-origin specialist in urology/ESWL lithotripsy systems (Dornier Delta, Compact Sigma). Direct competitor to MTS's lithogold380 in kidney-stone lithotripsy, particularly in hospital and urology-department capital sales.
• BTL Industries: Czech-headquartered device maker offering BTL-6000 SWT shockwave systems used in orthopaedics, physiotherapy, and urology (ED). Directly comparable in modality (ESWT for MSK and men's health) and in selling through clinical channels.
• Zimmer MedizinSysteme: German manufacturer of shockwave therapy systems (enPuls, enShock, Piezowave 2) for orthopaedics, sports medicine, and aesthetic medicine. Direct competitor to orthogold line in MSK and PT clinics.
• Richard Wolf GmbH: German-headquartered medical device company with a significant urology and ESWL/lithotripsy portfolio (including PiezoLith systems). Comparable to MTS in both product category (urology/lithotripsy) and German-mid-market manufacturing profile.

Emerging players

• Chattanooga Group (DJO Global / Enovis): Rehabilitation and orthopaedic device maker (part of Enovis) offering Intelect RPW shockwave and other PT/OT modalities to physiotherapy clinics. Comparable to MTS in the outpatient rehabilitation use case and customer segment (sports med/MSK clinics).
• EMS Electro Medical Systems: Swiss maker of Swiss DolorClast radial shockwave devices used in MSK, sports medicine, and aesthetic indications. Comparable in modality and customer base to MTS's orthopaedics-focused devices.
• Gymna: Belgian manufacturer of physiotherapy and rehabilitation equipment including shockwave and combination therapy devices. Comparable in that it sells shockwave units to physiotherapy and rehabilitation clinics, similar end customer to MTS orthogold.

Broad incumbents

• Siemens Healthineers: Large diversified medical-technology incumbent with presence in urology imaging, lithotripsy-adjacent systems, and broader hospital capital equipment. Not a direct ESWT competitor but shapes hospital procurement standards and competitive context for MTS in urology channels.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/MTSSparkWave
• YouTubeyoutube.com/@mtsmedical/featured
• Facebookfacebook.com/MTSmedical
• LinkedInlinkedin.com/company/mts-medical
• Instagraminstagram.com/mts.medical

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MTS Medical